|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 264.1 USD | -0.59% |
|
-0.89% | -8.32% |
| Apr. 17 | UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating | MT |
| Apr. 16 | Amgen Plans for Phase 3 Trial of Tezepelumab for Lung Disease | MT |
Salesforce.com Inc, Amgen Inc and Honeywell International Inc will become a part of the blue-chip Dow Jones Industrial Average index on Aug. 31, S&P Dow Jones Indices said on Monday.
The three companies will replace Exxon Mobil Corp, Pfizer Inc and Raytheon Technologies Corp.
The changes follow Apple Inc's decision to split its stock, which would reduce the index's weight in the global industry classification standard information technology sector, S&P Dow Jones Indices said.
(Reporting by Nivedita Balu in Bengaluru; Editing by Shounak Dasgupta)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 37,753 PTS | -0.12% | -1.44% | - | ||
| 17,494 PTS | -1.24% | -3.72% | - | ||
| 15,683 PTS | -1.15% | -3.82% | - | ||
| 5,022 PTS | -0.58% | -3.60% | - | ||
| 190.4 USD | -0.19% | -2.70% | 124B | ||
| 168 USD | -0.81% | +0.13% | 2,594B | ||
| 118.6 USD | -0.05% | -2.92% | 470B | ||
| 100.8 USD | -0.09% | -0.60% | 134B | ||
| 25.42 USD | -1.05% | -3.42% | 144B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -8.32% | 142B | |
| +28.79% | 676B | |
| +23.48% | 554B | |
| -7.64% | 349B | |
| +15.00% | 318B | |
| +5.99% | 291B | |
| +2.94% | 210B | |
| -0.37% | 204B | |
| -9.82% | 194B | |
| -11.71% | 144B |
AMGEN INC. 
